搜索
雅培
ABT添加自选
92.165USD
+1.425+1.57%
收盘 07/01, 16:00（美东）报价延迟15分钟
160.56B总市值
25.58市盈率 TTM
关于 雅培 公司
雅培是一家横跨全球的医疗保健领导者，专注于多元健康产品的研发、制造与销售，业务框架涵盖四大单元：成熟药品、诊断、营养以及医疗器械。成熟药品单元负责多品牌仿制药的国际行销；诊断单元向血库、医院、商业实验室与替代护理点提供检测系统与试剂；营养单元经营成人及儿童营养品全球通路；医疗器械单元销售节律管理、电生理、心衰、血管、结构心脏、神经调控及糖尿病护理装置，持续推动创新改善患者生命品质。其全球供应链覆盖六大洲，利用数据分析与可持续制造提升效率与品质保障。
雅培简介
公司代码ABT
公司名称Abbott Laboratories
上市日期Apr 06, 2073
CEOFord (Robert B)
员工数量114000
证券类型Ordinary Share
年结日Apr 06
公司地址100 Abbott Park Road
城市ABBOTT PARK
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编60064-3500
电话12246676100
网址https://www.abbott.com
公司代码ABT
上市日期Apr 06, 2073
CEOFord (Robert B)
雅培公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
90.41K
+20.44%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
76.84K
-1.49%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
71.54K
+28.74%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
--
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
36.34K
+6.29%
Mr. John G. Stratton
Mr. John G. Stratton
Independent Director
Independent Director
23.32K
+8.58%
Ms. Michelle A. Kumbier
Ms. Michelle A. Kumbier
Independent Director
Independent Director
18.00K
+12.70%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
90.41K
+20.44%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
76.84K
-1.49%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
71.54K
+28.74%
常见问题
雅培的前五大股东是谁？
雅培 的前五大股东如下：Mr. Daniel J. Starks
有多少机构持有雅培(ABT)的股份？
截至2026Q1，共有4859家机构持有雅培的股份，合计持有的股份价值约为1.25B，占公司总股份的71.75%。与2025Q4相比，机构持股有所增加，增幅为-187252308.00。
哪个业务部门对雅培的收入贡献最大？
在2026Q1，Diabetes Care业务部门对雅培的收入贡献最大，创收8.00B，占总收入的18.04%。